KYTHERA Biopharmaceuticals Files Registration Statement for Proposed Initial Public Offering
KYTHERA Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that it has publicly filed its registration statement on Form S-1 with the U.S.